Miceli Valentina, Gennarini Marco, Tomao Federica, Cupertino Angelica, Lombardo Dario, Palaia Innocenza, Curti Federica, Riccardi Sandrine, Ninkova Roberta, Maccioni Francesca, Ricci Paolo, Catalano Carlo, Rizzo Stefania Maria Rita, Manganaro Lucia
Department of Radiological, Oncology and Patological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, 00185 Rome, Italy.
Cancers (Basel). 2023 Dec 13;15(24):5827. doi: 10.3390/cancers15245827.
PC represents the most striking picture of the loco-regional spread of ovarian cancer, configuring stage III. In the last few years, many papers have evaluated the role of imaging and therapeutic management in patients with ovarian cancer and PC. This paper summed up the literature on traditional approaches to the imaging of peritoneal carcinomatosis in advanced ovarian cancer, presenting classification systems, most frequent patterns, routes of spread and sites that are difficult to identify. The role of imaging in diagnosis was investigated, with particular attention to the reported sensitivity and specificity data-computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography-CT (PET-CT)-and to the peritoneal cancer index (PCI). In addition, we explored the therapeutic possibilities and radiomics applications that can impact management of patients with ovarian cancer. Careful staging is mandatory, and patient selection is one of the most important factors influencing complete cytoreduction (CCR) outcome: an accurate pre-operative imaging may allow selection of patients that may benefit most from primary cytoreductive surgery.
盆腔种植转移是卵巢癌局部区域扩散最显著的表现,构成了Ⅲ期。在过去几年中,许多论文评估了影像学检查及治疗管理在卵巢癌合并盆腔种植转移患者中的作用。本文总结了有关晚期卵巢癌腹膜转移瘤传统影像学检查方法的文献,介绍了分类系统、最常见的表现形式、转移途径以及难以识别的部位。研究了影像学检查在诊断中的作用,特别关注所报道的敏感性和特异性数据——计算机断层扫描(CT)、磁共振成像(MRI)、正电子发射断层扫描-CT(PET-CT)——以及腹膜癌指数(PCI)。此外,我们还探讨了可能影响卵巢癌患者管理的治疗可能性和放射组学应用。仔细分期是必不可少的,而患者选择是影响完全细胞减灭术(CCR)结果的最重要因素之一:准确的术前影像学检查可以筛选出可能从初次细胞减灭术中获益最大的患者。